>
Immunodiagnostic Systems Holdings logo

IDH - Immunodiagnostic Systems Holdings Share Price

255p 0.0  0.0%

Last Trade - 14/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £73.4m
Enterprise Value £52.9m
Revenue £34.3m
Position in Universe 1142nd / 1826
Bullish
Bearish
Unlock IDH Revenue
Momentum
Relative Strength (%)
1m +40.9%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -39.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
45.4 38.3 40.0 37.9 38.5 39.3 148 3,503 -2.8%
-65.5 -59.5 -52.5 +244.8 -42.7
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 September 2020,Immunodiagnostic Systems Hldgs PLC revenues decreased 27%to £13.7M. Net loss totaled £3M vs. income of £16K.Revenues reflect Automated segment decrease of 25% to £8.2M, Manual segment decrease of 37% to £3.6M, Technologysegment decrease of 8% to £1.9M. Net loss reflectsTechnology segment loss increase of 2% to £587K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

IDH Revenue Unlock IDH Revenue

Net Income

IDH Net Income Unlock IDH Revenue

Normalised EPS

IDH Normalised EPS Unlock IDH Revenue

PE Ratio Range

IDH PE Ratio Range Unlock IDH Revenue

Dividend Yield Range

IDH Dividend Yield Range Unlock IDH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
IDH EPS Forecasts Unlock IDH Revenue
Profile Summary

Immunodiagnostic Systems Holdings PLC is a specialist in vitro diagnostic solution provider to the clinical laboratory market. The Company develops, manufactures and markets immunoassays and automated immunoanalyser technologies. It operates through three business segments: Automated IVD, Manual IVD, and Licensing & Technology. The automated IVD business consists of 25-OH Vitamin D, specialties and instrument sales. The automated IVD business also consists of the sale or placement of its IDS-iSYS instrument, in addition to selling automated assays and consumables for use in these instruments. The Manual IVD business sells manual assays, radio immunoassays (RIA) and ELISA kits (EIA) to labs. Its assay development is focused in the clinical areas, such as calcium metabolism, bone metabolism, chronic kidney disease, hypertension, fertility and growth. Its subsidiaries include Immunodiagnostic Systems Limited, Immunodiagnostic Systems Nordic A/S and Immunodiagnostic Systems France SAS.

Directors
Last Annual March 31st, 2020
Last Interim September 30th, 2020
Incorporated June 4, 2004
Public Since December 24, 2004
No. of Shareholders: n/a
No. of Employees: 295
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 28,784,097
Free Float (0.0%)
Eligible for
ISAs
SIPPs
IDH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for IDH
Upcoming Events for IDH
Monday 14th June, 2021 Estimate
Full Year 2021 Immunodiagnostic Systems Holdings PLC Earnings Release
Frequently Asked Questions for Immunodiagnostic Systems Holdings
What is the Immunodiagnostic Systems Holdings share price?

As of 14/05/21, shares in Immunodiagnostic Systems Holdings are trading at 255p, giving the company a market capitalisation of £73.4m. This share price information is delayed by 15 minutes.

How has the Immunodiagnostic Systems Holdings share price performed this year?

Shares in Immunodiagnostic Systems Holdings are currently trading at 255p and the price has moved by 15.91% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Immunodiagnostic Systems Holdings price has moved by -6.82% over the past year.

What are the analyst and broker recommendations for Immunodiagnostic Systems Holdings?

Of the analysts with advisory recommendations for Immunodiagnostic Systems Holdings, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Immunodiagnostic Systems Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Immunodiagnostic Systems Holdings next release its financial results?

Immunodiagnostic Systems Holdings is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Immunodiagnostic Systems Holdings dividend yield?

The Immunodiagnostic Systems Holdings dividend yield is 0.75% based on the trailing twelve month period.

Does Immunodiagnostic Systems Holdings pay a dividend?

Last year, Immunodiagnostic Systems Holdings paid a total dividend of 0.02, and it currently has a trailing dividend yield of 0.75%. Looking ahead, Immunodiagnostic Systems Holdings has not announced an ex-dividend date yet.

When does Immunodiagnostic Systems Holdings next pay dividends?

Immunodiagnostic Systems Holdings has yet to annouce their ex-dividend date. The historic dividend yield on Immunodiagnostic Systems Holdings shares is currently 0.75%.

How do I buy Immunodiagnostic Systems Holdings shares?

To buy shares in Immunodiagnostic Systems Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Immunodiagnostic Systems Holdings?

Shares in Immunodiagnostic Systems Holdings are currently trading at 255p, giving the company a market capitalisation of £73.4m.

Where are Immunodiagnostic Systems Holdings shares listed? Where are Immunodiagnostic Systems Holdings shares listed?

Here are the trading details for Immunodiagnostic Systems Holdings:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: IDH
What kind of share is Immunodiagnostic Systems Holdings?

Based on an overall assessment of its quality, value and momentum, Immunodiagnostic Systems Holdings is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Immunodiagnostic Systems Holdings share price forecast 2021?

Shares in Immunodiagnostic Systems Holdings are currently priced at 255p. At that level they are trading at 50.7% discount to the analyst consensus target price of 517.24.

Analysts covering Immunodiagnostic Systems Holdings currently have a consensus Earnings Per Share (EPS) forecast of 0.0507 for the next financial year.

How can I tell whether the Immunodiagnostic Systems Holdings share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Immunodiagnostic Systems Holdings. Over the past six months, the relative strength of its shares against the market has been 16.36%. At the current price of 255p, shares in Immunodiagnostic Systems Holdings are trading at 15.64% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Immunodiagnostic Systems Holdings PE Ratio?

We were not able to find PE ratio data for Immunodiagnostic Systems Holdings.

Who are the key directors of Immunodiagnostic Systems Holdings?

Immunodiagnostic Systems Holdings's management team is headed by:

Burkhard Wittek - NEC
Roland Sackers - NID
Till Campe - NED
Peter Williamson - NED
Andrew Davison - SEC
Klaus Kaspar - NED
Paul Martin - FID
Jaap Stuut - CEO
Who are the major shareholders of Immunodiagnostic Systems Holdings?

Here are the top five shareholders of Immunodiagnostic Systems Holdings based on the size of their shareholding:

Wittek (Burkhard) Individual Investor
Percentage owned: 27.69% (7.97m shares)
Schroder Investment Management Ltd. (SIM) Investment Advisor/Hedge Fund
Percentage owned: 11.35% (3.27m shares)
Frankfurter Aktienfonds fuer Stiftungen Mutual Fund
Percentage owned: 9.99% (2.88m shares)
Axxion S.A. Investment Advisor
Percentage owned: 9.71% (2.80m shares)
Baader Bank AG Investment Advisor/Hedge Fund
Percentage owned: 8.48% (2.44m shares)
Similar to IDH
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.